Literature DB >> 27432868

Protective Role of Kallistatin in Vascular and Organ Injury.

Julie Chao1, Grant Bledsoe2, Lee Chao2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27432868      PMCID： PMC4982811          DOI： 10.1161/HYPERTENSIONAHA.116.07861

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  100 in total

1.  Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling.

Authors:  Bo Shen; Lin Gao; Yi-Te Hsu; Grant Bledsoe; Makato Hagiwara; Lee Chao; Julie Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

2.  Kallistatin is a potent new vasodilator.

Authors:  J Chao; J N Stallone; Y M Liang; L M Chen; D Z Wang; L Chao
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein.

Authors:  W Xiong; C Q Tang; G X Zhou; L Chao; J Chao
Journal:  J Lab Clin Med       Date:  1992-05

Review 4.  Emerging avenues linking inflammation and cancer.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Free Radic Biol Med       Date:  2012-03-03       Impact factor: 7.376

5.  Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock.

Authors:  L M Chen; L Chao; J Chao
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

Review 6.  Pharmacological approaches to improve endothelial repair mechanisms.

Authors:  Christian Besler; Carola Doerries; Giovanna Giannotti; Thomas F Lüscher; Ulf Landmesser
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-09

7.  Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.

Authors:  Pengfei Li; Youming Guo; Grant Bledsoe; Zhirong Yang; Lee Chao; Julie Chao
Journal:  Exp Cell Res       Date:  2016-01-11       Impact factor: 3.905

8.  Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents.

Authors:  Haidong Zhu; Julie Chao; Ishita Kotak; Dehuang Guo; Samip J Parikh; Jigar Bhagatwala; Yutong Dong; Sagar Y Patel; Chris Houk; Lee Chao; Yanbin Dong
Journal:  Metabolism       Date:  2012-11-26       Impact factor: 8.694

9.  Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.

Authors:  Lin Gao; Pengfei Li; Jingmei Zhang; Makoto Hagiwara; Bo Shen; Grant Bledsoe; Eugene Chang; Lee Chao; Julie Chao
Journal:  J Am Heart Assoc       Date:  2014-09-18       Impact factor: 5.501

Review 10.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531
View more
  19 in total

1.  Kallistatin correlates with inflammation in abdominal aortic aneurysm and suppresses its formation in mice.

Authors:  Yuchen He; Yanshuo Han; Jia Xing; Xiaoyue Zhai; Shiyue Wang; Shijie Xin; Jian Zhang
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

2.  The COVIDome Explorer Researcher Portal.

Authors:  Kelly D Sullivan; Matthew D Galbraith; Kohl T Kinning; Kyle Bartsch; Nik Levinsky; Paula Araya; Keith P Smith; Ross E Granrath; Jessica R Shaw; Ryan Baxter; Kimberly R Jordan; Seth Russell; Monika Dzieciatkowska; Julie A Reisz; Fabia Gamboni; Francesca Cendali; Tusharkanti Ghosh; Andrew A Monte; Tellen D Bennett; Michael G Miller; Elena W Y Hsieh; Angelo D'Alessandro; Kirk C Hansen; Joaquin M Espinosa
Journal:  medRxiv       Date:  2021-03-08

Review 3.  Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.

Authors:  Julie Chao; Youming Guo; Pengfei Li; Lee Chao
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

4.  Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.

Authors:  Youming Guo; Pengfei Li; Lin Gao; Jingmei Zhang; Zhirong Yang; Grant Bledsoe; Eugene Chang; Lee Chao; Julie Chao
Journal:  Aging Cell       Date:  2017-05-24       Impact factor: 9.304

5.  Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock.

Authors:  Laura M Vilander; Mari A Kaunisto; Suvi T Vaara; Ville Pettilä
Journal:  Crit Care       Date:  2017-03-08       Impact factor: 9.097

Review 6.  The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies.

Authors:  Marcella Nebbioso; Alessandro Lambiase; Marta Armentano; Giosuè Tucciarone; Vincenza Bonfiglio; Rocco Plateroti; Ludovico Alisi
Journal:  Antioxidants (Basel)       Date:  2020-07-26

7.  Clinical Significance of Serum Kallistatin and ENOX1 Levels in Patients with Coronary Heart Disease.

Authors:  Rui Zhang; Zhenjun Ji; Junyan Cai; Yongjun Li; Genshan Ma
Journal:  Med Princ Pract       Date:  2020-07-24       Impact factor: 1.927

Review 8.  Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway.

Authors:  Julie Chao; Youming Guo; Pengfei Li; Lee Chao
Journal:  Oxid Med Cell Longev       Date:  2017-12-13       Impact factor: 6.543

Review 9.  Endothelial Cell Aging: How miRNAs Contribute?

Authors:  Munekazu Yamakuchi; Teruto Hashiguchi
Journal:  J Clin Med       Date:  2018-07-10       Impact factor: 4.241

10.  Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway.

Authors:  Youming Guo; Lee Chao; Julie Chao
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.